Sign in Join
Daily desk

News

Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.

2 stories

A blood-drop icon holding ten microRNA markers plus CA19-9 illustrates the PANXEON score, alongside its 86.8% stage I-II sensitivity, 96.8% specificity, and 1,785-patient cohort.
🩺 Health Study

A Blood-Based Score Combining Ten microRNAs and CA19-9 Flags Early Pancreatic Cancer in a 1,785-Person Study

A prospective 1,785-person study published in Nature Medicine on September 16, 2026, found that PANXEON — a blood test combining ten microR…

EduFabTech · 17 Sep 2026 · 4 min read
A CD3×CD19 bispecific antibody bridges a patient's T cell and a B cell, with key trial results — 12 patients, 80% reaching low disease activity, 60% meeting remission criteria.
🩺 Health Study

Phase 1 Trial Finds a Cancer-Style T-Cell Engager Can Push Refractory Lupus Into Remission

A phase 1 trial of A-319, a CD3×CD19 bispecific antibody adapted from cancer therapy, pushed most of 12 treatment-resistant lupus patients …

EduFabTech · 16 Sep 2026 · 4 min read